Suchergebnisse - "Schmid, Peter"

PubPharm (14)

1

TROPION-Breast02 : Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer

enthalten in: Future oncology (London, England) | 2023

von Dent, R. | Cescon, D. | Bachelot, T. | +9

2

Emerging strategies for TNBC with early clinical data : new chemoimmunotherapy strategies

enthalten in: Breast cancer research and treatment | 2022

von Hall, P. | Schmid, P.

3

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

enthalten in: The New England journal of medicine | 2021

von Bardia, A. | Hurvitz, S. | Tolaney, S. | +117

CommentIn: Nat Rev Clin Oncol. 2021 Jun;18(6):322. - PMID 33931767

4

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355) : a randomised, placebo-controlled, double-blind, phase 3 clinical trial

enthalten in: Lancet (London, England) | 2020

von Cortes, J. | Cescon, D. | Rugo, H. | +118

CommentIn: Lancet. 2021 Jul 3;398(10294):24. - PMID 34217392

5

FIR : Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2018

von Spigel, D. | Chaft, J. | Gettinger, S. | +11

6

Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Traina, T. | Miller, K. | Yardley, D. | +17

CommentIn: Cancer Discov. 2018 Apr;8(4):OF8. - PMID 29439153

7

A process for assessing the feasibility of a network meta-analysis : a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer

enthalten in: BMC medicine | 2014

von Cope, S. | Zhang, J. | Saletan, S. | +3

8

Quantification of pancreatic cancer proteome and phosphorylome : indicates molecular events likely contributing to cancer and activity of drug targets

enthalten in: PloS one | 2014

von Britton, D. | Zen, Y. | Quaglia, A. | +18

ErratumIn: PLoS One. 2014;9(8):e107077

9

High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer : overview of six randomized trials

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2011

von Berry, D. | Ueno, N. | Johnson, M. | +13

CommentIn: J Clin Oncol. 2011 Aug 20;29(24):3205-6. - PMID 21768457

10

Influence of a dose-dense adjuvant chemotherapy on sVCAM-1/sICAM-1 serum levels in breast cancer patients with 1-3 positive lymph nodes

enthalten in: Anticancer research | 2011

von Eggeman, H. | Stöblen, F. | Thill, M. | +7